Examining Emerging Competition Issues Involving Digital Health and Virtual Healthcare
Digital health and virtual healthcare have both rapidly expanded in recent years and recent high profile mergers in this area have attracted antitrust scrutiny. This panel will explore recent developments in this industry, the framework for assessing transactions by healthcare and technology companies, and potential theories of competitive effects.
Hosted by the ABA's Health Care and Pharmaceuticals Committee and Mergers and Acquisitions Committee.
- John Carroll, Sheppard Mullin
- Emily Cotton, Analysis Group
- Megan Browdie, Cooley LLP
- Stephen Rodger, Federal Trade Commission
Click here for more information and to register.